Hunan Hansen Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 470.46 million compared to CNY 462.51 million a year ago. Revenue was CNY 471.67 million compared to CNY 462.68 million a year ago.

Net income was CNY 90.67 million compared to CNY 78.88 million a year ago. Basic earnings per share from continuing operations was CNY 0.1802 compared to CNY 0.1568 a year ago. Diluted earnings per share from continuing operations was CNY 0.1802 compared to CNY 0.1568 a year ago.